Active surveillance Maintenance chemotherapy CTACAE Adjuvant treatment Surgical margin Recurrence Definitive treatment Minimal residual disease (MRD) Tumor Monoclonal antibody Clinical stage Relapse Cure Neoadjuvant treatment ECOG performance status Adenocarcinoma Complementary therapy Cellular therapy Refractory Checkpoint inhibitor Chemotherapy Tyrosine kinase inhibitors (TKIs) Maintenance chemotherapy Antibody Drug Conjugate (ADCs) Grade 3, 4, or 5 Sarcoma Pathological stage Partial Remission Palliation leukemia Complete remission TNM staging system Carcinoma performance status Active surveillance Maintenance chemotherapy CTACAE Adjuvant treatment Surgical margin Recurrence Definitive treatment Minimal residual disease (MRD) Tumor Monoclonal antibody Clinical stage Relapse Cure Neoadjuvant treatment ECOG performance status Adenocarcinoma Complementary therapy Cellular therapy Refractory Checkpoint inhibitor Chemotherapy Tyrosine kinase inhibitors (TKIs) Maintenance chemotherapy Antibody Drug Conjugate (ADCs) Grade 3, 4, or 5 Sarcoma Pathological stage Partial Remission Palliation leukemia Complete remission TNM staging system Carcinoma performance status
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Active surveillance
Maintenance chemotherapy
CTACAE
Adjuvant treatment
Surgical margin
Recurrence
Definitive treatment
Minimal residual disease (MRD)
Tumor
Monoclonal antibody
Clinical stage
Relapse
Cure
Neoadjuvant treatment
ECOG performance status
Adenocarcinoma
Complementary therapy
Cellular therapy
Refractory
Checkpoint inhibitor
Chemotherapy
Tyrosine kinase inhibitors (TKIs)
Maintenance chemotherapy
Antibody Drug Conjugate (ADCs)
Grade 3, 4, or 5
Sarcoma
Pathological stage
Partial Remission
Palliation
leukemia
Complete remission
TNM staging system
Carcinoma
performance status